Cargando…
Accrual, Publication Bias, and the Coronavirus in 2020
The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and th...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356711/ https://www.ncbi.nlm.nih.gov/pubmed/32462787 http://dx.doi.org/10.1634/theoncologist.2020-0455 |
_version_ | 1783558548363411456 |
---|---|
author | Bates, Susan E. |
author_facet | Bates, Susan E. |
author_sort | Bates, Susan E. |
collection | PubMed |
description | The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and the subsequent publication bias that this practice necessarily creates. As The Oncologist celebrates its 25th Anniversary, we focus not only on the ethical and moral imperatives behind CTR, but also on the practical goal of informing the practice of treating physicians. |
format | Online Article Text |
id | pubmed-7356711 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73567112020-07-17 Accrual, Publication Bias, and the Coronavirus in 2020 Bates, Susan E. Oncologist Editorials The era of COVID19 reflects the importance, perhaps now more than ever, of transparency in the outcomes of trials small and large. The Oncologist Clinical Trial Results (CTR) section has endeavored to provide a remedy for the persistent problem of underreporting in clinical trials in oncology and the subsequent publication bias that this practice necessarily creates. As The Oncologist celebrates its 25th Anniversary, we focus not only on the ethical and moral imperatives behind CTR, but also on the practical goal of informing the practice of treating physicians. John Wiley & Sons, Inc. 2020-05-29 2020-07 /pmc/articles/PMC7356711/ /pubmed/32462787 http://dx.doi.org/10.1634/theoncologist.2020-0455 Text en © AlphaMed Press 2020 |
spellingShingle | Editorials Bates, Susan E. Accrual, Publication Bias, and the Coronavirus in 2020 |
title | Accrual, Publication Bias, and the Coronavirus in 2020 |
title_full | Accrual, Publication Bias, and the Coronavirus in 2020 |
title_fullStr | Accrual, Publication Bias, and the Coronavirus in 2020 |
title_full_unstemmed | Accrual, Publication Bias, and the Coronavirus in 2020 |
title_short | Accrual, Publication Bias, and the Coronavirus in 2020 |
title_sort | accrual, publication bias, and the coronavirus in 2020 |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356711/ https://www.ncbi.nlm.nih.gov/pubmed/32462787 http://dx.doi.org/10.1634/theoncologist.2020-0455 |
work_keys_str_mv | AT batessusane accrualpublicationbiasandthecoronavirusin2020 |